BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
40 results:

  • 1. BUB1, bub1b, CCNA2, and CDCA8, along with miR-524-5p, as clinically relevant biomarkers for the diagnosis and treatment of endometrial carcinoma.
    Hao Q; Wu H; Liu E; Wang L
    BMC Cancer; 2023 Oct; 23(1):995. PubMed ID: 37853361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status.
    Villalona S; Ferrante J; Villalona S; Stroup A
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696662
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
    Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank.
    Ung CY; Warwick A; Onoufriadis A; Barker JN; Parsons M; McGrath JA; Shaw TJ; Dand N
    JAMA Dermatol; 2023 Feb; 159(2):172-181. PubMed ID: 36598763
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven cancers.
    Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
    Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma.
    Diggs A; Sia TY; Huang Y; Gockley A; Melamed A; Khoury-Collado F; St Clair C; Hou JY; Hershman DL; Wright JD
    Gynecol Oncol; 2022 Aug; 166(2):308-316. PubMed ID: 35660331
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
    Federico A; Anchora LP; Gallotta V; Fanfani F; Cosentino F; Turco LC; Bizzarri N; Legge F; Teodorico E; Macchia G; Valentini V; Scambia G; Ferrandina G
    Ann Surg Oncol; 2022 Aug; 29(8):4806-4814. PubMed ID: 35355131
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
    Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
    Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Post-recurrence survival in patients with cervical cancer.
    Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
    Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MRI guided focused ultrasound (MRgFUS) treatment for uterine fibroids among women with and without abdominal scars.
    Inbar Y; Machtinger R; Barnett-Itzhaki Z; Goldblatt A; Stoler E; Rabinovici J
    Int J Hyperthermia; 2021; 38(1):1672-1676. PubMed ID: 34843654
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
    Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.
    Samper Ots PM; Rovirosa Casino A; Herreros Martínez A; Rodriguez Villalba S; Pérez Calatayud J; Polo Cezón R; Gutiérrez Miguélez C; Anchuelo Latorre J; Rodríguez Rodríguez I; Córdoba Largo S; Pérez Echagüen S; Sanz Freire CJ; Clemente Gutiérrez F; De Las Peñas Cabrera D; Villafranca Iturre E;
    Clin Transl Oncol; 2021 Jun; 23(6):1193-1200. PubMed ID: 33237447
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
    Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
    Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real-world multicenter study of a large Chinese cohort from 2006 to 2017.
    Guo C; Tang X; Meng Y; Zhang Y; Zhang X; Guo J; Lei X; Qiu J; Hua K
    Cancer Med; 2020 Aug; 9(16):5908-5921. PubMed ID: 32628356
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
    Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
    PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Downregulation of Mad2 and bubr1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis.
    Wang L; Wang J; Jin Y; Zheng J; Yang Y; Xi X
    J Obstet Gynaecol Res; 2019 Dec; 45(12):2407-2418. PubMed ID: 31523901
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma.
    Zeng X; Baba T; Hamanishi J; Matsumura N; Kharma B; Mise Y; Abiko K; Yamaguchi K; Horikawa N; Hunstman DG; Mulati K; Kitamura S; Taki M; Murakami R; Hosoe Y; Mandai M
    Int J Cancer; 2019 Sep; 145(6):1635-1647. PubMed ID: 31228268
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?
    Hasegawa T; Furugori M; Kubota K; Asai-Sato M; Yashiro-Kawano A; Kato H; Oi Y; Shigeta H; Segawa K; Kitagawa M; Mine Y; Saji H; Numazaki R; Maruyama Y; Ohnuma E; Taniguchi H; Sugiura K; Miyagi E; Matsunaga T;
    Int J Clin Oncol; 2019 Sep; 24(9):1129-1136. PubMed ID: 31069549
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.